Identification of Purines and 7-Deazapurines as Potent and Selective Type I Inhibitors of Troponin I-Interacting Kinase (TNNI3K).

作者: Brian G. Lawhorn , Joanne Philp , Yongdong Zhao , Christopher Louer , Marlys Hammond

DOI: 10.1021/ACS.JMEDCHEM.5B00931

关键词: Troponin IMAP kinase kinase kinaseKinaseBiochemistryChemistryPurine metabolismStructure–activity relationshipPlasma protein bindingStereochemistryPurineIn vivo

摘要: A series of cardiac troponin I-interacting kinase (TNNI3K) inhibitors arising from 3-((9H-purin-6-yl)amino)-N-methyl-benzenesulfonamide (1) is disclosed along with fundamental structure–function relationships that delineate the role each element 1 for TNNI3K recognition. An X-ray structure bound to confirmed its Type I binding mode and used rationalize structure–activity relationship employed design potent, selective, orally bioavailable inhibitors. Identification 7-deazapurine heterocycle as a superior template (vs purine) elaboration by introduction C4-benzenesulfonamide C7- C8–7-deazapurine substituents produced compounds substantial improvements in potency (>1000-fold), general selectivity (10-fold improvement), pharmacokinetic properties (>10-fold increase poDNAUC). Optimal members have suitable use vitro vivo experiments aimed at elucidating cardi...

参考文章(44)
John C. Reader, Thomas P. Matthews, Suki Klair, Kwai-Ming J. Cheung, Jane Scanlon, Nicolas Proisy, Glynn Addison, John Ellard, Nelly Piton, Suzanne Taylor, Michael Cherry, Martin Fisher, Kathy Boxall, Samantha Burns, Michael I. Walton, Isaac M. Westwood, Angela Hayes, Paul Eve, Melanie Valenti, Alexis de Haven Brandon, Gary Box, Rob L. M. van Montfort, David H. Williams, G. Wynne Aherne, Florence I. Raynaud, Suzanne A. Eccles, Michelle D. Garrett, Ian Collins, Structure-guided evolution of potent and selective CHK1 inhibitors through scaffold morphing. Journal of Medicinal Chemistry. ,vol. 54, pp. 8328- 8342 ,(2011) , 10.1021/JM2007326
Jérome Guillard, Maÿlis Decrop, Nathalie Gallay, Claire Espanel, Elodie Boissier, Olivier Herault, Marie-Claude Viaud-Massuard, Synthesis and biological evaluation of 7-azaindole derivatives, synthetic cytokinin analogues. Bioorganic & Medicinal Chemistry Letters. ,vol. 17, pp. 1934- 1937 ,(2007) , 10.1016/J.BMCL.2007.01.033
Jeffrey M. Axten, Stuart P. Romeril, Arthur Shu, Jeffrey Ralph, Jesús R. Medina, Yanhong Feng, William Hoi Hong Li, Seth W. Grant, Dirk A. Heerding, Elisabeth Minthorn, Thomas Mencken, Nathan Gaul, Aaron Goetz, Thomas Stanley, Annie M. Hassell, Robert T. Gampe, Charity Atkins, Rakesh Kumar, Discovery of GSK2656157: An Optimized PERK Inhibitor Selected for Preclinical Development ACS Medicinal Chemistry Letters. ,vol. 4, pp. 964- 968 ,(2013) , 10.1021/ML400228E
H. D. Hollis Showalter, Alexander J. Bridges, Hairong Zhou, Anthony D. Sercel, Amy McMichael, David W. Fry, Tyrosine Kinase Inhibitors. 16. 6,5,6-Tricyclic Benzothieno[3,2-d]pyrimidines and Pyrimido[5,4-b]- and -[4,5-b]indoles as Potent Inhibitors of the Epidermal Growth Factor Receptor Tyrosine Kinase Journal of Medicinal Chemistry. ,vol. 42, pp. 5464- 5474 ,(1999) , 10.1021/JM9903949
Michael P. Clark, Kelly M. George, Roger G. Bookland, Jack Chen, Steven K. Laughlin, Kumar D. Thakur, Wenlin Lee, Jan R. Davis, Ed J. Cabrera, Todd A. Brugel, John C. VanRens, Matthew J. Laufersweiler, Jennifer A. Maier, Mark P. Sabat, Adam Golebiowski, Vijay Easwaran, Mark E. Webster, Biswanath De, George Zhang, Development of new pyrrolopyrimidine-based inhibitors of Janus kinase 3 (JAK3). Bioorganic & Medicinal Chemistry Letters. ,vol. 17, pp. 1250- 1253 ,(2007) , 10.1016/J.BMCL.2006.12.018
Sylvia Schmid, Martin Röttgen, Ulf Thewalt, Volkhard Austel, Synthesis and conformational properties of 2,6-bis-anilino-3-nitropyridines Organic and Biomolecular Chemistry. ,vol. 3, pp. 3408- 3421 ,(2005) , 10.1039/B508819B
Yasuhiro Morisawa, Mitsuru Kataoka, Hitoshi Nagahori, Toshiaki Sakamoto, Noritoshi Kitano, Kenichi Kusano, Kiyoshi Sato, Studies on anticoccidial agents. 13. Synthesis and anticoccidial activity of nitropyridine-2- and -3-sulfonamides and derivatives. Journal of Medicinal Chemistry. ,vol. 23, pp. 1376- 1380 ,(1980) , 10.1021/JM00186A017
Aleem Gangjee, Ojas A. Namjoshi, Michael A. Ihnat, Aaron Buchanan, The contribution of a 2-amino group on receptor tyrosine kinase inhibition and antiangiogenic activity in 4-anilinosubstituted pyrrolo[2,3-d]pyrimidines Bioorganic & Medicinal Chemistry Letters. ,vol. 20, pp. 3177- 3181 ,(2010) , 10.1016/J.BMCL.2010.03.064
H. Ahlbrecht, E.O. Düber, J. Epsztajn, R.M.K. Marcinkowski, Delocalisation, conformation and basicity of anilines Tetrahedron. ,vol. 40, pp. 1157- 1165 ,(1984) , 10.1016/S0040-4020(01)99321-4